Senescence and cancer—role and therapeutic opportunities
Cellular senescence is a state of stable, terminal cell cycle arrest associated with various
macromolecular changes and a hypersecretory, pro-inflammatory phenotype. Entry of cells …
macromolecular changes and a hypersecretory, pro-inflammatory phenotype. Entry of cells …
Cell cycle, CDKs and cancer: a changing paradigm
M Malumbres, M Barbacid - Nature reviews cancer, 2009 - nature.com
Tumour-associated cell cycle defects are often mediated by alterations in cyclin-dependent
kinase (CDK) activity. Misregulated CDKs induce unscheduled proliferation as well as …
kinase (CDK) activity. Misregulated CDKs induce unscheduled proliferation as well as …
Cellular mechanisms of tumour suppression by the retinoblastoma gene
DL Burkhart, J Sage - Nature Reviews Cancer, 2008 - nature.com
The retinoblastoma (RB) tumour suppressor gene is functionally inactivated in a broad
range of paediatric and adult cancers, and a plethora of cellular functions and partners have …
range of paediatric and adult cancers, and a plethora of cellular functions and partners have …
Oncogene-induced senescence as an initial barrier in lymphoma development
M Braig, S Lee, C Loddenkemper, C Rudolph… - Nature, 2005 - nature.com
Acute induction of oncogenic Ras provokes cellular senescence involving the
retinoblastoma (Rb) pathway, but the tumour suppressive potential of senescence in vivo …
retinoblastoma (Rb) pathway, but the tumour suppressive potential of senescence in vivo …
[HTML][HTML] CDK4: a master regulator of the cell cycle and its role in cancer
The cell cycle is regulated in part by cyclins and their associated serine/threonine cyclin-
dependent kinases, or CDKs. CDK4, in conjunction with the D-type cyclins, mediates …
dependent kinases, or CDKs. CDK4, in conjunction with the D-type cyclins, mediates …
Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma
We performed exome sequencing to detect somatic mutations in protein-coding regions in
seven melanoma cell lines and donor-matched germline cells. All melanoma samples had …
seven melanoma cell lines and donor-matched germline cells. All melanoma samples had …
Regulatory Mechanisms of Tumor Suppressor P16INK4A and Their Relevance to Cancer
J Li, MJ Poi, MD Tsai - Biochemistry, 2011 - ACS Publications
P16INK4A (also known as P16 and MTS1), a protein consisting exclusively of four ankyrin
repeats, is recognized as a tumor suppressor mainly because of the prevalence of genetic …
repeats, is recognized as a tumor suppressor mainly because of the prevalence of genetic …
Signaling through cyclin D-dependent kinases
YJ Choi, L Anders - Oncogene, 2014 - nature.com
Research over the past quarter century has identified cyclin D-dependent kinases, CDK4
and CDK6, as the major oncogenic drivers among members of the CDK superfamily …
and CDK6, as the major oncogenic drivers among members of the CDK superfamily …
The cell-cycle regulator CDK4: an emerging therapeutic target in melanoma
KE Sheppard, GA McArthur - Clinical Cancer Research, 2013 - AACR
The recent clinical success of targeted therapies in melanoma directed at the oncogene
BRAF validates the concept of targeting oncogenes. The p16-cyclin D-CDK4/6 …
BRAF validates the concept of targeting oncogenes. The p16-cyclin D-CDK4/6 …
Modeling high-grade serous ovarian carcinogenesis from the fallopian tube
AM Karst, K Levanon, R Drapkin - Proceedings of the …, 2011 - National Acad Sciences
High-grade serous ovarian carcinoma (HGSOC) is a lethal disease for which improved
screening and treatment strategies are urgently needed. Progress in these areas is impeded …
screening and treatment strategies are urgently needed. Progress in these areas is impeded …